Kentucky legislation · 2026 Regular Session
Kentucky SR201: A RESOLUTION encouraging Kentucky policymakers to study, develop, and implement economic development policies to incentivize biopharmaceutical investment and innovation in Kentucky.
Status: Passed both chambers, April 1, 2026
Encourage Kentucky policymakers to study, develop, and implement economic development policies to incentivize biopharmaceutical investment and innovation in the Commonwealth.
What the bill says
A resolution encouraging Kentucky policymakers to study, develop, and implement economic development policies to incentivize biopharmaceutical investment and innovation in Kentucky.
From the introduced text:
A RESOLUTION encouraging Kentucky policymakers to study, develop, and implement economic development policies to incentivize biopharmaceutical investment and innovation in Kentucky. WHEREAS, the Commonwealth has made significant investments in pharmaceutical research in recent years, both through recurring general fund commitments and consequential, one-time expenditures into projects like the LifeSciKY, a lab incubator accelerating science, entrepreneurship, education, and economic development; and WHEREAS, biopharmaceutical investment and innovation is a major economic driver, with the potential to bring many high-paying jobs to the Commonwealth; and WHEREAS, each phase of the biopharmaceutical innovation process requires immense amounts of brainpower and capital, and inventors and investors look to mitigate their risk by moving to locations that provide better investment incentives; and WHEREAS, the state of Indiana recently announced a $1 billion commitment in the form of tax credits to attract major biopharmaceutical companies to their state, with the goal of creating 100,000 new high-wage jobs over the next 10 years; and WHEREAS, the Commonwealth is home to many talented minds that, without the proper incentives, may move elsewhere to invest and develop these types of life-changing innovations; and WHEREAS, the Commonwealth would benefit greatly by implementing policies that strengthen biopharmaceutical investment and innovation and would attract and keep these important developments in the Commonwealth; NOW, THEREFORE, Be it resolved by the Senate of the General …
Sponsors
- Shelley Funke Frommeyer (R, SD-024) · primary sponsor
- Robert Stivers (R, SD-025)
Latest actions
- : adopted by voice vote
- : to Senate Floor
- : to Committee on Committees (S)
- : introduced in Senate
Subjects: Drugs And Medicines, Economic Development, Science And Technology
Common questions
- What is SR201?
- SR201 is a bill in the Kentucky Legislature (2026 Regular Session): A RESOLUTION encouraging Kentucky policymakers to study, develop, and implement economic development policies to incentivize biopharmaceutical investment and innovation in Kentucky.
- What does SR201 do?
- In its own words: A resolution encouraging Kentucky policymakers to study, develop, and implement economic development policies to incentivize biopharmaceutical investment and innovation in Kentucky.
- What is the status of SR201?
- Passed both chambers as of April 1, 2026. Latest action: adopted by voice vote (April 1, 2026).
- Who sponsored SR201?
- Shelley Funke Frommeyer (R, SD-024), with 1 co-sponsor.
- Where is the official record for SR201?
- On the Kentucky Legislature website: https://apps.legislature.ky.gov/record/26rs/sr201.html
Source: official Kentucky record. Tracked by Delilah, AI for legislation across all 50 states and Congress.